<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药明康德 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-17T11:20:50+08:00</updated>
  <subtitle>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>ADC分水岭： CDMO选择是通向成功的最后关隘</title>
    <updated>2020-12-17T08:04:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/WitO3Kx9rc3UgxzG3XYvtw</id>
    <link href="https://mp.weixin.qq.com/s/WitO3Kx9rc3UgxzG3XYvtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《自然》揭晓年度十大人物，李兰娟院士、张永振教授等上榜</title>
    <updated>2020-12-17T08:04:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/Apzh-7qx-ouU3dyU4yLpyg</id>
    <link href="https://mp.weixin.qq.com/s/Apzh-7qx-ouU3dyU4yLpyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 12：1！诺华重磅心衰药诺欣妥获FDA咨询委员会支持扩展适用范围</title>
    <updated>2020-12-17T08:04:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/Nc1ZmTU7WN141RF4-iJbMA</id>
    <link href="https://mp.weixin.qq.com/s/Nc1ZmTU7WN141RF4-iJbMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 诺华潜在“first-in-class”口服补体通路抑制剂获FDA突破性疗法认定</title>
    <updated>2020-12-17T08:04:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/x7XQRiRsaSeMInqn2tUL6g</id>
    <link href="https://mp.weixin.qq.com/s/x7XQRiRsaSeMInqn2tUL6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 改善阿尔茨海默病患者认知指标，创新口服疗法达到2b/3期临床主要终点</title>
    <updated>2020-12-17T08:04:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/j2lf96AcV99zlxIicYkEkQ</id>
    <link href="https://mp.weixin.qq.com/s/j2lf96AcV99zlxIicYkEkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 免疫调节疫苗获FDA突破性疗法认定，与抗PD-1抗体联合治疗黑色素瘤</title>
    <updated>2020-12-17T08:04:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/CBsOCVPUEqeahvvweIVE8Q</id>
    <link href="https://mp.weixin.qq.com/s/CBsOCVPUEqeahvvweIVE8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>展现防护无症状感染潜力，FDA公布Moderna新冠疫苗详细数据</title>
    <updated>2020-12-16T07:32:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/qGxw49ZkOM2UI08Ig-sgbw</id>
    <link href="https://mp.weixin.qq.com/s/qGxw49ZkOM2UI08Ig-sgbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《自然》公布2020十大科学发现，半数来自生物医学领域</title>
    <updated>2020-12-16T07:32:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/VnWzXozkZKr-s9vsNn6VEw</id>
    <link href="https://mp.weixin.qq.com/s/VnWzXozkZKr-s9vsNn6VEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来拟斥资逾10亿美元收购基因疗法新锐，开拓神经退行性疾病新治疗模式</title>
    <updated>2020-12-16T07:32:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/Kkccv4NcsAxOypGfECLUmA</id>
    <link href="https://mp.weixin.qq.com/s/Kkccv4NcsAxOypGfECLUmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 治疗紫外线引起皮肤癌前病变，FDA批准创新外用疗法</title>
    <updated>2020-12-16T07:32:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/7nD0CZjtc904TR7Qyo8oZg</id>
    <link href="https://mp.weixin.qq.com/s/7nD0CZjtc904TR7Qyo8oZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 有望成为首款FDA批准疗法，武田创新糖皮质激素配方获优先审评资格</title>
    <updated>2020-12-16T07:32:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/AdKP49dMdiLBV6eMS1Cczg</id>
    <link href="https://mp.weixin.qq.com/s/AdKP49dMdiLBV6eMS1Cczg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明日下午3点！大动物疾病模型——赋能新药研发并提高临床转化成功率</title>
    <updated>2020-12-16T07:32:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/bvnfAgAGp6i-WP4W6aBq1Q</id>
    <link href="https://mp.weixin.qq.com/s/bvnfAgAGp6i-WP4W6aBq1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>展现“best-in-class”潜力，靶向蛋白降解疗法最新临床结果积极（附PPT）</title>
    <updated>2020-12-15T08:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/dtYEJ2hC_3NNEUtP4unmQg</id>
    <link href="https://mp.weixin.qq.com/s/dtYEJ2hC_3NNEUtP4unmQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>保护效力达91.4%，俄罗斯新冠疫苗完成3期临床试验疗效最终分析</title>
    <updated>2020-12-15T08:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/s6xbpwe_kIBjx7vMjMW9HA</id>
    <link href="https://mp.weixin.qq.com/s/s6xbpwe_kIBjx7vMjMW9HA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | FDA批准基因工程改造家猪，可能用于生产潜在人类疗法</title>
    <updated>2020-12-15T08:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/8ZsTtR3aglIi_kMGAvz8uA</id>
    <link href="https://mp.weixin.qq.com/s/8ZsTtR3aglIi_kMGAvz8uA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 开发KRAS组合疗法，基因泰克达成超7亿美元合作</title>
    <updated>2020-12-15T08:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/zbLHtHF_Aj32-Axh4Nw9nw</id>
    <link href="https://mp.weixin.qq.com/s/zbLHtHF_Aj32-Axh4Nw9nw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速递 | 提高癌症切除成功率，创新荧光成像剂获FDA突破性疗法认定</title>
    <updated>2020-12-15T08:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/sK46Fw0HjxTqMR9V5hc79g</id>
    <link href="https://mp.weixin.qq.com/s/sK46Fw0HjxTqMR9V5hc79g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《细胞》：吃那么多脂肪，都喂了癌细胞？难怪十几种癌症都爱找胖的人……</title>
    <updated>2020-12-15T08:02:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ewuJ3kxUCMR7iNCiO5uFLA</id>
    <link href="https://mp.weixin.qq.com/s/ewuJ3kxUCMR7iNCiO5uFLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>390亿美元并购，阿斯利康为何青睐Alexion?</title>
    <updated>2020-12-14T07:19:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/rwz1Mv7sXMX7TmKFIV6bpw</id>
    <link href="https://mp.weixin.qq.com/s/rwz1Mv7sXMX7TmKFIV6bpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞/BioNTech新冠疫苗获FDA紧急使用授权；阿斯利康390亿美元收购罕见病药物公司Alexion</title>
    <updated>2020-12-14T07:19:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/10X5ZiThd4DkTM2WWZz5jA</id>
    <link href="https://mp.weixin.qq.com/s/10X5ZiThd4DkTM2WWZz5jA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>